Francisco Gelpi‐Hammerschmidt

Brigham and Women's Hospital, Massachusetts General Hospital

Papers

4

Total Citations

91

H-Index

3

About

Francisco Gelpi‐Hammerschmidt is a urologic surgeon and researcher whose work focuses on improving surgical outcomes and understanding healthcare utilization in urologic oncology. His major contributions center on population-based analyses of complex urologic procedures. In a landmark 10-year study (66 citations), he examined trends, perioperative outcomes, and costs of nephroureterectomies for upper tract urothelial carcinoma, providing critical data on contemporary utilization and morbidity beyond single-institution series. He also investigated predictors of positive surgical margins after radical prostatectomy, identifying both preoperative and pathologic factors as well as the impact of surgeon variability. Additionally, his population-based analysis of rhabdomyolysis following extirpative renal surgery (10 citations) shed light on the incidence and consequences of this serious complication, offering evidence to guide perioperative care. Through these studies, Gelpi‐Hammerschmidt has advanced the understanding of surgical quality, cost-effectiveness, and patient safety in urologic oncology, making his work valuable for clinicians and researchers seeking to optimize surgical decision-making and outcomes.

Research Focus

Key Achievements

3
H-Index
4
Papers
91
Total Citations
23
Avg Citations/Paper
🏆 Most Cited Paper
Trends in utilisation, perioperative outcomes, and costs of nephroureterectomies in the management of upper tract urothelial carcinoma: a 10‐year population‐based analysis
66 citations · 2015
📈 Most Prolific Year: 2015 (3 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: Brigham and Women's Hospital, Massachusetts General Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago